Form 8-K/A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K/A

 

 

(Amendment No. 3)

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act 1934

Date of Report (date of earliest event reported): June 6, 2018

 

 

MIMEDX GROUP, INC.

(Exact name of registrant as specified in charter)

 

Florida   001-35887   26-2792552
(State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)

 

1775 West Oak Commons Ct, NE

Marietta, GA

    30062
(Address of principal executive offices)    (Zip Code)

(770) 651-9100

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Explanatory Note

MiMedx Group, Inc. (the “Company”) files this Amendment No. 3 to correct a second typographical error (in the signature block) in Exhibit 10.1

 

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits

 

10.1 Form of Change in Control Severance and Restrictive Covenant Agreement for Edward J. Borkowski.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

   

MIMEDX GROUP, INC.

Date: June 25, 2018

    

By:

   /s/ Alexandra O. Haden
       

Alexandra O. Haden

General Counsel & Secretary